(ORCU) Direxion Daily ORCL Bull 2X - Overview
ETF Category: Trading--Leveraged Equity | Exchange: NASDAQ (USA) | Market Cap: 50m USD | Total Return: -23.3% in 12m
Avg Turnover: 20.6M
Warnings
No concerns identified
Tailwinds
No distinct edge detected
The Direxion Daily ORCL Bull 2X ETF (ORCU) is a leveraged exchange-traded fund designed to provide 200% of the daily price performance of Oracle Corporation common stock. To achieve this objective, the fund invests at least 80% of its assets in Oracle securities and various financial derivatives, including swap agreements and options. As a non-diversified instrument, the fund focuses its risk exposure specifically on the price fluctuations of a single equity issuer.
Oracle Corporation operates primarily within the enterprise software and cloud computing sectors, utilizing a business model centered on high-margin software licenses and recurring cloud service subscriptions. The company has increasingly transitioned toward an Infrastructure-as-a-Service (IaaS) model to compete in the expanding global cloud infrastructure market. For a deeper look into these underlying business fundamentals, investors may find ValueRays analytical tools useful. Because this ETF resets daily, it is intended for short-term tactical trading rather than long-term buy-and-hold strategies.
- Oracle cloud infrastructure revenue growth accelerates to meet enterprise AI demand
- NetSuite and Fusion ERP expansion drives high-margin recurring software revenue
- Strategic partnerships with major hyperscalers increase Oracle database availability and adoption
- High interest rates impact debt servicing costs for aggressive acquisition strategy
- Leveraged daily reset structure amplifies volatility and compounding risk for shareholders
As of May 29, 2026, the stock is trading at USD 17.27 with a total of 1,881,690 shares traded.
Over the past week, the price has changed by +17.01%,
over one month by +47.10%,
over three months by +80.25% and
over the past year by -23.26%.
Direxion Daily ORCL Bull 2X has no consensus analysts rating.